Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide T-Cell Immunotherapy Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4483333
  • 117 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of T-Cell Immunotherapy in recent years and the growth of consumers' demand is expected to drive the global T-Cell Immunotherapy market.

Geographically, the global T-Cell Immunotherapy market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total T-Cell Immunotherapy market in North America.

Significant participants active in the global T-Cell Immunotherapy market include: Juno Therapeutics, Kite Pharma, Altor Bioscience Corporation, Cellectis, Adaptimmune, Novartis, Unum Therapeutics, Takara Bio, Biotecnol...

Global T-Cell Immunotherapy Market Segmentation:

T-Cell Immunotherapy market, by T-Cell Immunotherapy type:

CAR-T

TCR

TIL Therapies

…

T-Cell Immunotherapy market, by Application:

Stomach Cancer

Lung Cancer

Colorectal Cancer

Esophagus Cancer

Pancreatic Cancer

Others

…

T-Cell Immunotherapy Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of T-Cell Immunotherapy by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global T-Cell Immunotherapy Market-Segmentation

4.1 By Type

4.1.1 CAR-T

4.1.2 TCR

4.1.3 TIL Therapies

4.2 By End-User/Application Industry

4.2.1 Stomach Cancer

4.2.2 Lung Cancer

4.2.3 Colorectal Cancer

4.2.4 Esophagus Cancer

4.2.5 Pancreatic Cancer

4.2.6 Others

4.3 By Geography

4.3.1 North America T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America T-Cell Immunotherapy Production from 2014-2020

4.3.1.2 North America T-Cell Immunotherapy Consumption from 2014-2020

4.3.1.3 North America T-Cell Immunotherapy Import and Export from 2014-2020

4.3.1.4 North America T-Cell Immunotherapy Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America T-Cell Immunotherapy Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America T-Cell Immunotherapy Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe T-Cell Immunotherapy Production from 2014-2020

4.3.2.2 Europe T-Cell Immunotherapy Consumption from 2014-2020

4.3.2.3 Europe T-Cell Immunotherapy Import and Export from 2014-2020

4.3.2.4 Europe T-Cell Immunotherapy Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe T-Cell Immunotherapy Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific T-Cell Immunotherapy Production from 2014-2020

4.3.3.2 Asia-Pacific T-Cell Immunotherapy Consumption from 2014-2020

4.3.3.3 Asia-Pacific T-Cell Immunotherapy Import and Export from 2014-2020

4.3.3.4 Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America T-Cell Immunotherapy Production from 2014-2020

4.3.4.2 Latin America T-Cell Immunotherapy Consumption from 2014-2020

4.3.4.3 Latin America T-Cell Immunotherapy Import and Export from 2014-2020

4.3.4.4 Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa T-Cell Immunotherapy Production from 2014-2020

4.3.5.2 Middle East & Africa T-Cell Immunotherapy Consumption from 2014-2020

4.3.5.3 Middle East & Africa T-Cell Immunotherapy Import and Export from 2014-2020

4.3.5.4 Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Juno Therapeutics

5.1.1 Juno Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Juno Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Kite Pharma

5.2.1 Kite Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Kite Pharma Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Altor Bioscience Corporation

5.3.1 Altor Bioscience Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Altor Bioscience Corporation Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Cellectis

5.4.1 Cellectis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Cellectis Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Adaptimmune

5.5.1 Adaptimmune Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Adaptimmune Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Novartis

5.6.1 Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Unum Therapeutics

5.7.1 Unum Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Unum Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Takara Bio

5.8.1 Takara Bio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Takara Bio Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Biotecnol

5.9.1 Biotecnol Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Biotecnol Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global T-Cell Immunotherapy Market from 2021-2026

7.1 Future Forecast of Global T-Cell Immunotherapy Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global T-Cell Immunotherapy Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global T-Cell Immunotherapy Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global T-Cell Immunotherapy Market Value ($) and Growth Rate of T-Cell Immunotherapy from 2014-2026

Global T-Cell Immunotherapy Production and Growth Rate Segment by Product Types from 2014-2026F

Global T-Cell Immunotherapy Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global T-Cell Immunotherapy Production and Growth Rate Segment by Product Types from 2014-2020

Table Global T-Cell Immunotherapy Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure CAR-T of T-Cell Immunotherapy

Figure TCR of T-Cell Immunotherapy

Figure TIL Therapies of T-Cell Immunotherapy

Table Global T-Cell Immunotherapy Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global T-Cell Immunotherapy Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Stomach Cancer of T-Cell Immunotherapy

Figure Lung Cancer of T-Cell Immunotherapy

Figure Colorectal Cancer of T-Cell Immunotherapy

Figure Esophagus Cancer of T-Cell Immunotherapy

Figure Pancreatic Cancer of T-Cell Immunotherapy

Figure Others of T-Cell Immunotherapy

Table Global T-Cell Immunotherapy Production Value ($) by Regions

Table Global T-Cell Immunotherapy Production Value Share by Regions

Table Global T-Cell Immunotherapy Production by Regions

Table Global T-Cell Immunotherapy Production Share by Regions

Table Global T-Cell Immunotherapy Consumption by Regions

Table Global T-Cell Immunotherapy Consumption Share by Regions

Figure North America T-Cell Immunotherapy Production and Growth Rate from 2014-2020

Figure North America T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020

Table North America T-Cell Immunotherapy Import and Export from 2014-2020

Table North America T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

Table North America T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

Table North America T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

Figure Europe T-Cell Immunotherapy Production and Growth Rate from 2014-2020

Figure Europe T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020

Table Europe T-Cell Immunotherapy Import and Export from 2014-2020

Table Europe T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

Table Europe T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

Table Europe T-Cell Immunotherapy Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific T-Cell Immunotherapy Production and Growth Rate from 2014-2020

Figure Asia-Pacific T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020

Table Asia-Pacific T-Cell Immunotherapy Import and Export from 2014-2020

Table Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

Figure Latin America T-Cell Immunotherapy Production and Growth Rate from 2014-2020

Figure Latin America T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020

Table Latin America T-Cell Immunotherapy Import and Export from 2014-2020

Table Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

Table Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

Table Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa T-Cell Immunotherapy Production and Growth Rate from 2014-2020

Figure Middle East & Africa T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020

Table Middle East & Africa T-Cell Immunotherapy Import and Export from 2014-2020

Table Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019

Table Juno Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Juno Therapeutics Sales and Growth Rate from 2014-2020

Figure Juno Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Kite Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Kite Pharma Sales and Growth Rate from 2014-2020

Figure Kite Pharma Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Altor Bioscience Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Altor Bioscience Corporation Sales and Growth Rate from 2014-2020

Figure Altor Bioscience Corporation Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Cellectis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Cellectis Sales and Growth Rate from 2014-2020

Figure Cellectis Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Adaptimmune Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Adaptimmune Sales and Growth Rate from 2014-2020

Figure Adaptimmune Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Novartis Sales and Growth Rate from 2014-2020

Figure Novartis Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Unum Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Unum Therapeutics Sales and Growth Rate from 2014-2020

Figure Unum Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Takara Bio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Takara Bio Sales and Growth Rate from 2014-2020

Figure Takara Bio Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Biotecnol Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Biotecnol Sales and Growth Rate from 2014-2020

Figure Biotecnol Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global T-Cell Immunotherapy Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global T-Cell Immunotherapy Production and Growth Rate Forecast by Regions (2021-2026)

Table Global T-Cell Immunotherapy Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global T-Cell Immunotherapy Production and Growth Rate Forecast by Types (2021-2026)

Table Global T-Cell Immunotherapy Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390